Samaneh Ebrahimi
Shiraz, Fars, 0098, Iran
NCT Number: NCT01404468
The optimisation of drug absorption through skin is of great value in modern therapy.Phonophoresis is the use of therapeutic ultrasound to increase percutaneous drug absorption. However,few studies have compared pulsed and continuous modes of therapeutic ultrasound.This study compared these two modes by investigating the effect of lidocaine phonophoresis on sensory blockade.
Ninety-three healthy volunteers, assigned at random to one of three ultrasound groups:pulsed(ultrasound+lidocaine),continuous(ultrasound+lidocaine)and control(sham ultrasound+lidocaine).
Lidocaine was administered transdermally using a transducer.Two point discrimination, touch and maximum pain thresholds were assessed before and after the intervention in each group.
Pulsed ultrasound with topical lidocaine gel induced greater anaesthetic effect compared with continuous ultrasound with topical lidocaine gel and lidocaine application alone. The mechanical properties of pulsed ultrasound appear to be responsible for greater drug penetration.
Looking for future studies?
Notify Me18 year–28 year
All sexes
Interventional
Early Phase 1
Shiraz, Fars, 0098, Iran
Lidocaine is a common local anaesthetic drug that is used topically to relieve pain,itching and burning, and also for minor surgery.However,its application via this conductive method,has been confined to surface anaesthesia because it seems that it is not possible to have a deep transmission with local drug massage, without injection or systematic administration.On the other hand,the injection of lidocaine can lead to tissue injury and pain,and its use is not advised in children. Phonophoresis is one of the common procedures for reducing these problems. Therefore, the main aim of this study was to compare the two modes of therapeutic ultrasound by assessing the effect of lidocaine gel phonophoresis on percutaneous absorption and sensory blockade.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lidocaine (approximately 2 cc) was administered transdermally using a transducer (pulsed ultrasound)
Other names: lidocainegel(Akron,Inc.,Lake Forest,CA,USA), ultrasound(Enraf,Sonopuls 434,Netherlands)
off device with Lidocaine (approximately 2 cc) was administered transdermally
Other names: ultrasound(Enraf,Sonopuls 434,Netherlands)
Lidocaine (approximately 2 cc) was administered transdermally using a transducer (continuous ultrasound )
Other names: lidocaine gel(Akron, Inc.,Lake Forest,CA,USA), ultrasound (Enraf,Sonopuls 434,Netherlands)
Time frame: imediately after finishing the application of ultrasound (5 minutes after intervention)
Shiraz University of Medical Sciences
Other
Effect of Lidocaine Phonophoresis on Sensory Blockade: Pulsed or Continuous Mode of Therapeutic Ultrasound?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07533409
Communication Disorders, Learning Disabilities
Edirne, Turkey (Türkiye)
View Trial DetailsNCT07025161
Neurologic Manifestations, Pain
Orlando, Florida, United States
View Trial DetailsNCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT06869369
Behavior, Motor Activity
Kütahya, Turkey (Türkiye)
View Trial Details